ADAC adds to management team
Nuclear medicine and RIS/PACS vendor ADAC Laboratories has brought some new faces to its management team. James Haisler has been named COO of the vendor’s Dallas-based healthcare information systems division. Haisler most recently served as
Nuclear medicine and RIS/PACS vendor ADAC Laboratories has brought some new faces to its management team. James Haisler has been named COO of the vendors Dallas-based healthcare information systems division. Haisler most recently served as president of the diagnostic imaging division of Phymatrix, and has also served as president and COO of Dornier Medical Systems. PACS veteran Kevin Flynn has been tapped as vice president of sales at ADAC HCIS. Flynn previously served as vice president of sales for Dome Imaging Systems, and prior to that was national sales manager for the clinical networking division of Siemens Medical Systems.
In other ADAC news, the Milpitas, CA-based firm reported that it has received orders for a record 10 C-PET units in its fiscal first quarter (end-January). In fiscal 1999, ADAC had been booking sales of three to five units per quarter. Among the new customers are Barnes Jewish Hospital in St. Louis, and the San Raffaele Hospital and Research Center in Milan, Italy.
ADAC also announced that it would settle the consolidated class action lawsuit pending against the firm. Under the agreement-in-principle, ADAC would pay the plaintiff class $20 million in full settlement of its claims.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.
